DIVIDEND ANNOUNCEMENT: Rubius Therapeutics Inc (OTCBB:RUBY) on 12/22/2023 declared a dividend of $0.0579 per share

Rubius Therapeutics Inc (OTCBB:RUBY) on 12/22/2023 declared a dividend of $ 0.0579 per share payable on December 29, 2023 to shareholders of record as of December 26, 2023. Dividend amount recorded is an increase of $ 0.0579 from last dividend Paid.

Rubius Therapeutics Inc (OTCBB:RUBY) has paid dividends since 1970, has a current dividend yield of 0.0000000000% and has increased its dividends for 0 successive years.

Rubius Therapeutics Inc's market cap is $ 1,807,960 and has a PE ratio of 0.00. The stock price closed yesterday at $ 0.02 and has a 52 week low/high of $ 0.00 and $ 0.42.

Rubius Therapeutics is a clinical-stage biopharmaceutical company that is biologically engineering red blood cells to develop a class of cellular medicines called Red Cell Therapeutics for the treatment of cancer and autoimmune diseases. Co.'s platform, RED PLATFORM, biologically engineers and cultures allogeneic red blood cell therapies that enable multiple applications, or modalities. Co.'s immune stimulation for the treatment of cancer includes RTX-240, which is designed to stimulate the immune system by activating and expanding both NK and CD8+ memory T cells to generate an anti-tumor response; and RTX-224, which is designed as an immune agonist of both adaptive and innate responses.

For more information on Rubius Therapeutics Inc click here.